Today, Xavier Ayala, president and founder of the charity organisation Vi per Vida, founded in March 2014, has presented Jo
"Vi per Vida" makes its first donation to metastasis research at IRB Barcelona
Jerzy Duszyński elected President of the Polish Academy of Science
The three prizes for “Secondary Research” projects given to work mentored by IRB Barcelona researchers
2M€ for studying protein motions and their implications for the treatment of prostate cancer
Biochemist Jerzy Duszyński, current member of IRB Barcelona's Board of Trustees and head of the
Yesterday, Wednesday March 11, La Pedrera Auditorium hosted the awarding of prizes for the «Tutoring for Secondary School Students»,
The European Research Council (ERC) has awarded a Consolidator Grant to ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Lab
Radio 5 (RNE) has broadcasted a report on a molecule developed by IRB Barcelona capable of crossing the barrier that protects the brain and transporting drugs inside. The breakthrough made by the Peptide and Protein Laboratory was recently published in Angewandte Chemie.
The business section of “La Vanguardia”, in addition to other media and organizations, have highlighted the Consolidator Grant awarded by the European Research Council (ERC) to the project led by ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Laboratory at IRB Barcelona. The results of this project could lead to new drugs for prostate cancer.
The “Gaceta Médica” newspaper has published an article about the computational resource dSysMap, developed by the Laboratory of Structural Bioinformatics and Network Biology at IRB Barcelona, led by ICREA researcher Patrick Aloy. The article includes statements by Aloy.
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
Felice Alessio Bava
ex PhD student in the Translational Control of Cell Cycle and Differentiation Lab
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
Quick facts about IRB
IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.
IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.
The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.
Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.